| URL | https://www.thepharmaletter.com/pharmaceutical/tex |
| Source | thepharmaletter.com |
| Date Published | 09/24/2025 |
| Company/Division name | Eli Lilly |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2030 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 6500 |
| City reshored to: | Houston |
| State(s) reshored to: | TX |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals |